In a suspension of thrombin degranulated platelets (TDP), ADP and epinephrine can induce platelet aggregation, whereas the synthetic agonist of the thromboxane/endoperoxide receptor U46619 causes only shape change. However, U46619 can enhance platelet aggregation induced by ADP and epinephrine. In this paper, we have measured fibrinogen binding in relation to phospholipase C(PLC) activation and calcium mobilization in TDP activated by ADP, epinephrine and U46619.
ADP caused fibrinogen binding in TDP but neither activated PLC nor caused a calcium mobilization. The requirement for ADP in inducing exposure of fibrinogen binding sites was not absolute since the combination of epinephrine and U46619 produced an increase in fibrinogen binding. U46619 caused significant PLC activation and cytosolic calcium release but not fibrinogen binding. These results suggest that in TDP the exposure of fibrinogen binding sites, after agonist activation, is independent of both PLC activation and calcium mobilization.
References
1
Pytela R,
Pierschbacher MD,
Ginsberg MH,
Plow EF,
Ruoslahti E.
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Sci 1986; 231: 1559-1562
2
Gartner TK,
Bennet JS.
The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985; 260: 11891-11894
5
Morinelli TA,
Niewiarowski S,
Kornecki E,
Figures WR,
Wachtfogel Y,
Colman RW.
Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. Blood 1983; 61: 41-49
8
Ashby B,
Daniel JL,
Smith JB.
Mechanisms of platelet activation and inhibition. In: Hematology/Oncology Clinics of North America. Platelets in health and disease
Colman RW,
Rao AK.
eds.
Philadelphia: Saunders Company; 1990. pp 1-26
10
Marguerie GA,
Plow EF,
Edgington TS.
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363
11
Grynkiewicz G,
Poenie M,
Tsien RY.
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3445
12
Pulcinelli FM,
Gazzaniga PP,
Salganicoff L.
Use of Zn-pyrophosphatase in the high-performance liquid chromatographic analysis of cell extracts containing 32P-labelled inositol phosphates. J Chromatogr 1992; 575: 51-55
15
Ingerman CM,
Smith JB,
Shapiro S,
Sedar A,
Silver MJ.
Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood 1978; 52: 332-344
17
Shattil SJ,
Budzynski A,
Scrutton MC.
Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989; 73: 150-158
22
Hillery CA,
Smyth SS,
Parise LV.
Phosphorylation of human platelet glycoprotein IIIa (GPIIIa). Dissociation from fibrinogen binding receptor activation and phosphorylation of GPIIIa in vitro J Biol Chem 1991; 266: 14663-14669
24
Morii N,
Teru-uchi T,
Tominaga T,
Kumagai N,
Kozaki S,
Ushikubi F,
Narumiya S.
A rho gene product in human blood platelets. II. Effect of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation J Biol Chem 1992; 267: 20921-20926
